Sidley Austin represented Roche in the transaction, and Cooley represented Poseida Therapeutics. Roche, one of the world’s largest biotechnology companies and the global leader in in-vitro...
Roche’s $1.5 Billion Acquisition of Poseida Therapeutics
Vignette Bio’s Merger with Candid Therapeutics
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Vignette Bio in the transaction, and Cooley represented Candid Therapeutics. Candid Therapeutics, a biotechnology company, acquired Vignette Bio...
Hipgnosis Songs’ $200 Million Acquisition of Justin Bieber’s Music Rights
Cooley advised Justin Bieber on the deal. Justin Bieber announced a $200 million deal to sell his music rights to Blackstone-backed Hipgnosis Songs Capital. The deal is...
Amgen’s Acquisition of Horizon Therapeutics
Cooley LLP and Matheson LLP advised Horizon, while Sullivan & Cromwell LLP and William Fry LLP advised Amgen. Debevoise & Plimpton LLP advised JP Morgan. Macfarlanes...
Poseida Therapeutics’ Collaboration and License Agreement With Roche
Cooley advised Poseida Therapeutics on the deal. Poseida Therapeutics, a clinical-stage biopharmaceutical company, announced its strategic collaboration and license agreement with Roche. The agreement will leverage Poseida’s...
Shoreline Biosciences’ Strategic Collaboration with BeiGene
Cooley LLP advised Shoreline Biosciences on the deal. Shoreline Biosciences, a biotechnology company developing immunotherapies for cancer and other serious diseases, announced its worldwide strategic collaboration with...